5 Healthcare Stock Earnings Snapshots

Abiomed Inc. (NASDAQ:ABMD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 50% to $0.09 in the quarter versus EPS of $0.06 in the year-earlier quarter. Revenue Rose 17.03% to $43.7 million from the year-earlier quarter.

Abiomed Inc. reported adjusted EPS income of $0.09 per share. By that measure, the company beat the mean analyst estimate of $0.07. It beat the average revenue estimate of $41.95 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ABMD

Palomar Medical Technologies Inc. (NASDAQ:PMTI) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.06 in the quarter versus EPS of $-0.12 in the year-earlier quarter. Revenue Rose 22.11% to $23.2 million from the year-earlier quarter.

Palomar Medical Technologies Inc. reported adjusted EPS loss of $0.06 per share. By that measure, the company missed the mean analyst estimate of $0. It beat the average revenue estimate of $20.26 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

PMTI

QLT Inc. (NASDAQ:QLTI) had a loss and beat Wall Street’s expectations, AND met the revenue expectation. Adjusted Earnings Per Share increased to $-0.13 in the quarter versus EPS of $-0.21 in the year-earlier quarter. Revenue Decreased 100% to $0 from the year-earlier quarter.

QLT Inc. reported adjusted EPS loss of $0.13 per share. By that measure, the company beat the mean analyst estimate of $-0.14. It met the average revenue estimate of $0.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

QLTI

Nxstage Medical, Inc. (NASDAQ:NXTM) had a loss and met Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.08 in the quarter versus EPS of $-0.09 in the year-earlier quarter. Revenue Rose 8.17% to $61.6 million from the year-earlier quarter.

Nxstage Medical, Inc. reported adjusted EPS loss of $0.08 per share. By that measure, the company met the mean analyst estimate of $-0.08. It beat the average revenue estimate of $61.14 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

NXTM

Incyte Corporation (NASDAQ:INCY) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.12 in the quarter versus EPS of $-0.36 in the year-earlier quarter. Revenue Rose 96.52% to $71.1 million from the year-earlier quarter.

Incyte Corporation reported adjusted EPS loss of $0.12 per share. By that measure, the company beat the mean analyst estimate of $-0.2. It beat the average revenue estimate of $68.16 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

INCY

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.